ARKG ETF
ARK Genomic Revolution ETF
ARKG ETF Overview
ARKG ETF (ARK Genomic Revolution ETF) is managed by Ark Invest with $2.22B in net assets. ARKG expense ratio is 0.75%, holding 32 positions across sectors including Health Care, Information Technology. Inception date: 2014-10-31.
ARKG performance shows a YTD return of 85.82%. The 1-year return is 95.19% and the 5-year return is -11.11%.
ARKG top holdings include Twist Bioscience Corp. (9.9%), Tempus Pe (8.9%), 10x Genomics Inc Com Usd 1 Cl A (8.1%), Absci Corp (5.3%), Crispr Therapeutics Ag Common Shares (5.2%). Go to all ARKG holdings, ARKG sectors, or ARKG dividends.
ARKG can be compared against other funds. Use ARKG overlap to find shared positions, or ARKG vs another fund for a side-by-side view. ARKG alternatives are available via the screener, along with tax-loss harvesting opportunities.